The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia

Background and Objectives Sickle cell anemia (SCA) and glucose-6-phosphate dehydrogenase (G6PD) deficiency are both hereditary diseases of the red blood cells that cause hemolysis. The impact of the interaction of both conditions on the clinical and laboratory presentations of the affected persons i...

Full description

Bibliographic Details
Main Authors: Hilary Nnamezie Igwilo, Lateef Salawu, Tewogbade Adeoye Adedeji
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Plasmatology
Online Access:https://doi.org/10.1177/26348535211040528
id doaj-a0eab93d926549b19bb871227be587c5
record_format Article
spelling doaj-a0eab93d926549b19bb871227be587c52021-09-08T21:33:19ZengSAGE PublishingPlasmatology2634-85352021-09-011510.1177/26348535211040528The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell AnemiaHilary Nnamezie Igwilo0Lateef Salawu1Tewogbade Adeoye Adedeji2 Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria. Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.Background and Objectives Sickle cell anemia (SCA) and glucose-6-phosphate dehydrogenase (G6PD) deficiency are both hereditary diseases of the red blood cells that cause hemolysis. The impact of the interaction of both conditions on the clinical and laboratory presentations of the affected persons is sparse. This study, therefore, correlated G6PD activity with disease severity in persons with SCA by comparing disease severity in G6PD-deficient SCA persons with those with normal G6PD activity. Methodology This cross-sectional study was conducted in the department of Haematology and Blood Transfusion of the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria. G6PD activity, SCA disease severity, and hematological parameters including reticulocyte counts and Heinz body estimation, bilirubin, and aspartate transaminase were estimated in 67 SCA persons. The results were compared between SCA persons with G6PD deficiency and those with normal enzyme activity. Results The prevalence of G6PD deficiency was found to be 23.9%. The G6PD-deficient SCA patients included 4 (25.0%) males and 12 (75.0%) females. G6PD deficiency was significantly higher in females ( P  = .047). There was no significant difference in disease severity scores between G6PD-deficient and G6PD-nondeficient SCA patients. However, G6PD-deficient persons reported significantly higher episodes of severe vasoocclusive crisis (VOC) per annum ( P  = .048). The hematological and biochemical parameters were similar between G6PD-deficient and G6PD normal SCA persons except that the G6PD-deficient SCA persons have significantly higher reticulocyte response ( P  = .001). There was no correlation between disease severity resulting from reduced G6PD activity and Heinz body formation in SCA persons in the steady state. Conclusion G6PD deficiency significantly contributes to recurrent painful vasoocclusive crisis in SCA persons in the steady state.https://doi.org/10.1177/26348535211040528
collection DOAJ
language English
format Article
sources DOAJ
author Hilary Nnamezie Igwilo
Lateef Salawu
Tewogbade Adeoye Adedeji
spellingShingle Hilary Nnamezie Igwilo
Lateef Salawu
Tewogbade Adeoye Adedeji
The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
Plasmatology
author_facet Hilary Nnamezie Igwilo
Lateef Salawu
Tewogbade Adeoye Adedeji
author_sort Hilary Nnamezie Igwilo
title The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
title_short The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
title_full The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
title_fullStr The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
title_full_unstemmed The Impact of Glucose-6-Phosphate Dehydrogenase Deficiency on the Frequency of Vasoocclusive Crisis in Patients with Sickle Cell Anemia
title_sort impact of glucose-6-phosphate dehydrogenase deficiency on the frequency of vasoocclusive crisis in patients with sickle cell anemia
publisher SAGE Publishing
series Plasmatology
issn 2634-8535
publishDate 2021-09-01
description Background and Objectives Sickle cell anemia (SCA) and glucose-6-phosphate dehydrogenase (G6PD) deficiency are both hereditary diseases of the red blood cells that cause hemolysis. The impact of the interaction of both conditions on the clinical and laboratory presentations of the affected persons is sparse. This study, therefore, correlated G6PD activity with disease severity in persons with SCA by comparing disease severity in G6PD-deficient SCA persons with those with normal G6PD activity. Methodology This cross-sectional study was conducted in the department of Haematology and Blood Transfusion of the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria. G6PD activity, SCA disease severity, and hematological parameters including reticulocyte counts and Heinz body estimation, bilirubin, and aspartate transaminase were estimated in 67 SCA persons. The results were compared between SCA persons with G6PD deficiency and those with normal enzyme activity. Results The prevalence of G6PD deficiency was found to be 23.9%. The G6PD-deficient SCA patients included 4 (25.0%) males and 12 (75.0%) females. G6PD deficiency was significantly higher in females ( P  = .047). There was no significant difference in disease severity scores between G6PD-deficient and G6PD-nondeficient SCA patients. However, G6PD-deficient persons reported significantly higher episodes of severe vasoocclusive crisis (VOC) per annum ( P  = .048). The hematological and biochemical parameters were similar between G6PD-deficient and G6PD normal SCA persons except that the G6PD-deficient SCA persons have significantly higher reticulocyte response ( P  = .001). There was no correlation between disease severity resulting from reduced G6PD activity and Heinz body formation in SCA persons in the steady state. Conclusion G6PD deficiency significantly contributes to recurrent painful vasoocclusive crisis in SCA persons in the steady state.
url https://doi.org/10.1177/26348535211040528
work_keys_str_mv AT hilarynnamezieigwilo theimpactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
AT lateefsalawu theimpactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
AT tewogbadeadeoyeadedeji theimpactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
AT hilarynnamezieigwilo impactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
AT lateefsalawu impactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
AT tewogbadeadeoyeadedeji impactofglucose6phosphatedehydrogenasedeficiencyonthefrequencyofvasoocclusivecrisisinpatientswithsicklecellanemia
_version_ 1717761871322284032